Suramin Derivatives as Inhibitors and Activators of Protein-tyrosine Phosphatases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Suramin Derivatives as Inhibitors and Activators of Protein-tyrosine Phosphatases

Published:2004-04 Issue:15 Volume:279 Page:14713-14725
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

McCain Daniel F.,Wu Li,Nickel Peter,Kassack Matthias U.,Kreimeyer Annett,Gagliardi Antonio,Collins Delwood C.,Zhang Zhong-Yin

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference87 articles.

1. Suramin: With Special Reference to Onchocerciasis

2. Suramin Is an Active Site-directed, Reversible, and Tight-binding Inhibitor of Protein-tyrosine Phosphatases

3. Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.

4. Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.

5. Protein tyrosine phosphatases: prospects for therapeutics

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-Benzylaminomethyl Lithocholic Acid Derivatives Exhibited Potent and Selective Uncompetitive Inhibitory Activity Against Protein Tyrosine Phosphatase 1B (PTP1B);ACS Omega;2024-07-21

2. Suramin: Effectiveness of analogues reveals structural features that are important for the potent trypanocidal activity of the drug;Experimental Parasitology;2024-05

3. Impact of Suramin on Key Pathological Features of Sporadic Alzheimer’s Disease-Derived Forebrain Neurons;Journal of Alzheimer's Disease;2024-03-05

4. The importance of including the C-terminal domain of PTP1B _1-400 to identify potential antidiabetic inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-03-30

5. Urea-based anticancer agents. Exploring 100-years of research with an eye to the future;Frontiers in Chemistry;2022-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3